期刊文献+

结肠癌细胞HIF-1α及MDR1 miRNA重组慢病毒干扰体系多药耐药研究 被引量:5

Multidrug Resistance of Colon Cancer Cells HIF-1α and MDR1 miRNA Lentivirus Interference System
下载PDF
导出
摘要 目的研究HIF-1α及MDR1 miRNA重组慢病毒干扰体系的多药耐药性。方法收集结肠癌切除的标本60例,用福尔马林(10%)浸泡,制成蜡块存档标本。通过观察HIF-1α与P-gp的表达和分布情况,找出二者关联。并构建miRAN干扰体系,研究重组慢病毒干扰体系和结肠癌细胞多药耐药的关系。结果 HIF-1α的表达与患者的性别、年龄、肿瘤的位置以及肿瘤分化的程度无关(P>0.05),而与Dukes分期、淋巴结转移有关。HIF-1α表达与P-gp的表达呈显著正相关(γ=0.613,P<0.05)。Lo Vo细胞对ADR、VCR及5-Fu的敏感性均有不同程度的恢复,但沉默HIF-1α前后并无统计学差异(P>0.05),沉默MDR1基因后,Lo Vo细胞对ADR与VCR的耐药性有所逆转,沉默MDR1基因表达对二者化疗敏感性变化无明显影响。结论 HIF-1α与P-gp的表达不受患者的性别、年龄、肿瘤位置、分化程度的影响,HIF-1α表达与P-gp的表达呈显著正相关,说明HIF-1α通过与MDR1/P-gp的相互作用最终参与了结肠癌多药耐药的发生。 Objective To study multidrug HIF-1α and MDR1 miRNA lentivirus system interference resistance. Methods 60 cases of colon cancer resection specimens soaked with the formalin( 10% ) , made of wax block archived specimens. Correlation between HIF-1α and P-gp were detected by observing their expression and distribution. Build, recombinant lentivirus relationship miRAN system interference interference system and colon cancer cells multidrug resistance. Results The gender, age,location of the tumor and the degree of tumor differentiation were independent of the expression of HIF-1 ( P 〉 0.05 ) , which was related to Dukes stage and lymph node metastasis. SHIF-1 expression was significantly positively correlated with P-gp expression (y = 0. 613, P 〈 0.05 ). ADR, VCR and LoVo cells on the sensitivity of 5-Fu had different degrees of recovery, but there was no significant difference between before and after silencing HIF-1 alpha ( P 〉 0.05 ) , MDR1 gene silencing, the drug resistance of LoVo cells to ADR and VCR have reversed, silencing the expression of MDR1 had no significant effect on the change of chemotherapy sensitivity. Conclusion HIF-1α and P-gp expression are not affected by gender,age,and location,differentiation degree. HIF-1α and P-gp expression are positively correlated, and HIF-1α eventually involved in the occurrence of colon cancer multidrug resist- ance by interacting with MDR1/P-gp.
出处 《实用癌症杂志》 2017年第4期545-547,552,共4页 The Practical Journal of Cancer
关键词 结肠癌 HIF-1Α MIRNA P-糖蛋白 多药耐药 慢病毒载体 Colon cancer HfF-1α miRNA P-gp Multidrug resistance Lentiviral vectors
  • 相关文献

参考文献5

二级参考文献91

  • 1张正茂,田拥军,孟忠吉,雷延昌,李新宇,王宝菊,杨东亮.RNA干扰抑制人乙型肝炎病毒复制的研究[J].中国病毒学,2006,21(4):348-352. 被引量:6
  • 2黄丽芳,李君君,孔卫红,颜家运.RNA干扰PCGF4/Bmi-1抑制白血病K562细胞系增殖[J].陕西医学杂志,2007,36(3):296-299. 被引量:5
  • 3Shike M, Winawer SJ, Greenwald PH, Bloch A, Hill MJ, Swaroop SV. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1990; 68:377-385.
  • 4Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; (1): CD001216.
  • 5Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6:60.
  • 6Birchler JA, Kavi HH. Molecular biology. Slicing and dicing for small RNAs. Science 2008; 320: 1023-1024.
  • 7Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
  • 8Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36:D154-D158.
  • 9Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11:441-450.
  • 10Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.

共引文献62

同被引文献59

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部